Home/Filings/4/0001723128-19-000019
4//SEC Filing

Branning Todd P. 4

Accession 0001723128-19-000019

CIK 0001723128other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 5:45 PM ET

Size

7.6 KB

Accession

0001723128-19-000019

Insider Transaction Report

Form 4
Period: 2019-01-22
Branning Todd P.
SVP, Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2019-01-22+80,38680,386 total
    Class A Common Stock (80,386 underlying)
  • Award

    Stock Option

    2019-01-22+163,666163,666 total
    Exercise: $12.44Exp: 2029-01-22Class A Common Stock (163,666 underlying)
Footnotes (3)
  • [F1]The option vests in four equal annual installments beginning on January 22, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning on January 22, 2020 and have no expiration date.

Issuer

Amneal Pharmaceuticals, Inc.

CIK 0001723128

Entity typeother

Related Parties

1
  • filerCIK 0001765274

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:45 PM ET
Size
7.6 KB